6938
prepared in an analogous fashion from 12, where Me4NBH(OAc)3 reduction gave the
intermediate 1,3-anti diol with >97% ds, which was then followed by deprotection.
In summary, the boron-mediated aldol reactions of the (Z)-enals 3 and 7 have been found to
proceed with unexpectedly high levels of 1,4-stereoinduction arising from the g-substituent.
Reagent control from (+)-Ipc2BCl can be used to overturn the strong facial bias of the aldehyde
component, thus enabling the stereocontrolled formation of (+)-discodermolide (1) and epimeric
analogues at C5 and C7. Further studies are underway to explore the generality and origin of
these eects, as well as the tubulin binding and polymerisation activity of the discodermolide
analogues prepared.
Acknowledgements
We thank the EPSRC (GR/M46686 and L41646) and Merck, Sharp & Dohme for support.
References
1. (a) ter Haar, E.; Kowalski, R. J.; Hamel, E.; Lin, C. M.; Longley, R. E.; Gunasekera, S. P.; Rosenkranz, H. S.;
Day, B. W. Biochemistry 1996, 35, 243. (b) Schreiber, S. L.; Chen, J.; Hung, D. T. Chem. Biol. 1996, 3, 287.
(c) Kowalski, R. J.; Giannakakou, P.; Gunasekera, S. P.; Longley, R. E.; Day, B. W.; Hamel, E. Mol. Pharmacol.
1997, 52, 613. (d) Balachandran, R.; ter Haar, E.; Welsh, M. J.; Grant, S. G.; Day, B. W. Anti-Cancer Drugs 1998,
9, 67. (e) Martello, L. A.; McDaid, H. M.; Regl, D. L.; Yang, C. P. H.; Meng, D. F.; Pettus, T. R. R.; Kaufman,
M. D.; Arimoto, H.; Danishefsky, S. J.; Smith III, A. B.; Horwitz, S. B. Clinical Cancer Research 2000, 6, 1978.
2. Gunasekera, S. P.; Gunasekera, M.; Longley, R. E.; Schulte, G. K. J. Org. Chem. 1990, 55, 4912.
3. Paterson, I.; Florence, G. J.; Gerlach, K.; Scott, J. P. Angew. Chem., Int. Ed. Engl. 2000, 39, 377.
4. For other total syntheses of (+)-discodermolide, see: (a) Nerenberg, J. B.; Hung, D. T.; Somers, P. K.; Schreiber,
S. L. J. Am. Chem. Soc. 1993, 115, 12621. (b) Hung, D. T.; Nerenberg, J. B.; Schreiber, S. L. J. Am. Chem. Soc.
1996, 118, 11054. (c) Marshall, J. A.; Johns, B. A. J. Org. Chem. 1998, 63, 7885. (d) Smith III, A. B.; Kaufman,
M. D.; Beauchamp, T. J.; LaMarche, M. J.; Arimoto, H. Org. Lett. 1999, 1, 1823.
5. For completed syntheses of antipodal (^)-discodermolide, see: (a) Smith III, A. B.; Qui, Y.; Jones, D. R.;
Kobayashi, K. J. Am. Chem. Soc. 1995, 117, 12011. (b) Harried, S. S.; Yang, G.; Strawn, M. A.; Myles, D. C.
J. Org. Chem. 1997, 62, 6098.
6. (a) Paterson, I.; Goodman, J. M.; Lister, M. A.; Schumann, R. C.; McClure, C. K.; Norcross, R. D. Tetrahedron
1990, 46, 4663. (b) Paterson, I.; Oballa, R. M.; Norcross, R. D. Tetrahedron Lett. 1996, 37, 8581.
7. For a review on aldol reactions using boron enolates, see: Cowden, C. J.; Paterson, I. Org. React. 1997, 51, 1.
8. (a) Paterson, I.; Goodman, J. M.; Isaka, M. Tetrahedron Lett. 1989, 30, 7121. (b) Paterson, I.; Norcross, R. D.;
Ward, R. A.; Romea, P.; Lister, M. A. J. Am. Chem. Soc. 1994, 116, 11287. (c) Paterson, I.; Gibson, K. R.;
Oballa, R. M. Tetrahedron Lett. 1996, 37, 8585. (d) Paterson, I.; Oballa, R. M. Tetrahedron Lett. 1997, 38, 8241.
9. Aldehyde 7 was prepared in eight steps (52%) by the following sequence.
(a) c-Hex2BCl, Et3N, Et2O, 0ꢀC, 3 h; MeCHO, ^78!^20ꢀC, 16 h; H2O2, MeOH, pH 7 buer; (b) SmI2, EtCHO,
THF, ^10ꢀC, 1.5 h; K2CO3, MeOH, rt, 1.5 h; (c) TBSOTf, 2,6-lutidine, CH2Cl2, ^78ꢀC, 2 h; (d) 20% Pd(OH)2/C,
H2, EtOH, 20ꢀC, 20 h; (e) DMP, CH2Cl2, rt, 1.5 h; (f) (CF3CH2O)2P(O)CH2CO2Me, KHMDS, 18-crown-6, THF,
^78ꢀC, 1.5 h; (g) DIBAL, CH2Cl2, ^78ꢀC, 1.5 h; (h) DMP, CH2Cl2, rt, 1.5 h.
10. All new compounds gave spectroscopic data in agreement with the assigned structures. The aldol stereochemistry
1
was established by H NMR analysis of the (R)- and (S)-MTPA esters based on the advanced Mosher method:
Ohtani, I.; Kusumi, T.; Kashman, Y.; Kakisawa, H. J. Am. Chem. Soc. 1991, 113, 4092.